SCHEMBL22632306

SCHEMBL22632306

CC(=O)NCCc1cc(=O)oc2cc(NCCN(C)C)ccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1B P49286 3/20 0.53
▸ MTNR1A P48039 2/20 0.53
▸ RAD52 P43351 1/20 0.47
▸ SLC18A1 P54219 1/20 0.47
▸ SLC18A2 Q05940 1/20 0.47
▸ ATM Q13315 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ CA12 O43570 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ CA1 P00915 1/20 0.44
▸ MAP2K1 Q02750 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ HSD17B3 P37058 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24623269 0.89 RAD52 (0.45) MTNR1BMTNR1ARAD52SLC18A1SLC18A2
SCHEMBL22632088 0.86 SLC18A1 (0.54) RAD52SLC18A1SLC18A2ATMMEN1
SCHEMBL24623266 0.83 RAD52 (0.48) RAD52SLC18A1SLC18A2ATMMEN1
SCHEMBL24623582 0.83 RAD52 (0.48) RAD52SLC18A1SLC18A2ATMMEN1
SCHEMBL22632228 0.81 MTNR1A (0.58) MTNR1BMTNR1ASLC18A1SLC18A2ATM
SCHEMBL22632226 0.78 MTNR1B (0.60) MTNR1BMTNR1ASLC18A1SLC18A2ATM
SCHEMBL22632089 0.77 ALDH1A1 (0.67) MTNR1BMTNR1ASLC18A1SLC18A2ATM
SCHEMBL22632322 0.76 MTNR1A (0.82) MTNR1BMTNR1AATMMEN1KMT2A
SCHEMBL22632307 0.72 MTNR1A (0.53) MTNR1BMTNR1ASLC18A1SLC18A2KDM4E
SCHEMBL15082514 0.70 HSD17B3 (0.72) KMT2ACA12CA9KDM4EHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223174-A1 COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER HEALTH RESEARCH, INC. (US) 2020-11-05 — — WO disclosed
Send feedback